McKesson doesn't expect Rite Aid's bankruptcy to have much affect on profit outlook, liquidity
McKesson Corp. (MCK) disclosed Monday that it doesn't expect drugstore chain Rite Aid Corp.'s (RAD) bankruptcy announced over the weekend to have a material impact on its adjusted earnings outlook for fiscal 2024. The health care supply and retail pharmacy company added that Rite Aid's bankruptcy isn't expected to have a material impact on its liquidity position or operations. McKesson's stock was still inactive in premarket trading, while Rite Aid shares were halted. On Aug. 2, McKesson said it expects fiscal 2024 adjusted EPS of $26.55 to $27.35,which compares with the current FactSet consensus of $27.19. The company is slated to release fiscal second-quarter results on Nov. 1. McKesson's stock has rallied 13% over the past three months through Friday while the S&P 500 has slipped 3.9%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-16-23 0729ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations